Search

everythinglearnresearchcommunity

for

Search:↓

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Early onset hair loss linked to genetics and androgen levels.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Higher sebum levels are linked to more severe male baldness.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride lowers cortisol and raises testosterone levels in rats.

Dutasteride reduces DHT more effectively than finasteride.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Dutasteride works better than finasteride for preventing and treating prostate cancer.